Here's Why Buying Coronavirus Stocks Can Be Risky
Many of the hottest stocks on the markets right now are those of companies developing potential vaccines or treatments for COVID-19, or businesses that are well-suited to the transformed economic conditions of the coronavirus pandemic. While new COVID-19 cases may continue to pop up for many years, investors shouldn't assume the pandemic is a long-term situation and ought to avoid investing based on that assumption.
vaccine heres risky
FoolRelated Articles
Novavax Launches Midstage Coronavirus Vaccine Trial
Novavax Launches Midstage Coronavirus Vaccine Trial
Vaccine specialist Novavax (NASDAQ:NVAX) announced the launch of a phase 2b clinical trial in South Africa to test the effectiveness of its coronavirus vaccine, NVX-CoV2373. Novavax is somewhat behind the leaders in the race for an approved vaccine for COVID-19, but the level of transmission in South Africa may give the company a chance to evaluate the efficacy of its vaccine very quickly.
vaccine novavax midstage
Fool
China announced $1 billion loan to South America to access coronavirus vaccine
Chinese Foreign Minister Wang Yi announced a $1 billion loan to Latin America and the Caribbean for Covid-19 vaccine access during a virtual gathering with his Latin American counterparts on Wednesday, according to a statement released by the Mexican Foreign Affairs Ministry. "China's Foreign Minister said that the vaccine developed in his country will be a public benefit of universal access"
america china vaccine latin
CNN
COVID-19 vaccine from Oxford shows positive results
COVID-19 vaccine from Oxford shows positive results
A potential COVID-19 vaccine developed by Oxford University with pharmaceutical giant AstraZeneca has produced a promising immune response in a large, early-stage human trial, according to newly released data published Monday in the medical journal The Lancet. The researchers are calling their experimental vaccine ChAdOx1 nCoV-19 (AZD1222)
vaccine trial oxford coronavirus
CNBC
Coronavirus vaccine should not be distributed to “The Highest Bidder”
Microsoft Founder Bill Gates said that Covid-19 medication and future vaccines should be distributed to people who need them the most and not to “the highest bidder.” “If we just let drugs and vaccines go to the highest bidder, instead of to the people and the places where they are most needed, we’ll have a longer, more unjust deadlier pandemic,” Gates said in a remote conference
vaccine billgates coronavirus
CNBC